Riverbridge Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,415
| Closed | -$307K | – | 187 |
|
|
2025
Q1 | $307K | Hold |
3,415
| – | – | ﹤0.01% | 163 |
|
|
2024
Q4 | $273K | Hold |
3,415
| – | – | ﹤0.01% | 165 |
|
|
2024
Q3 | $307K | Buy |
+3,415
| New | +$287K | ﹤0.01% | 157 |
|
|
2024
Q1 | – | Sell |
-4,129
| Closed | -$340K | – | 192 |
|
|
2023
Q4 | $340K | Buy |
4,129
+78
| +2% | +$5.95K | ﹤0.01% | 164 |
|
|
2023
Q3 | $317K | Hold |
4,051
| – | – | ﹤0.01% | 167 |
|
|
2023
Q2 | $357K | Sell |
4,051
-10
| -0.2% | -$861 | ﹤0.01% | 162 |
|
|
2023
Q1 | $327K | Hold |
4,061
| – | – | ﹤0.01% | 165 |
|
|
2022
Q4 | $316K | Hold |
4,061
| – | – | ﹤0.01% | 170 |
|
|
2022
Q3 | $328K | Hold |
4,061
| – | – | ﹤0.01% | 168 |
|
|
2022
Q2 | $364K | Hold |
4,061
| – | – | 0.01% | 163 |
|
|
2022
Q1 | $451K | Hold |
4,061
| – | – | 0.01% | 138 |
|
|
2021
Q4 | $420K | Sell |
4,061
-2,005
| -33% | -$232K | ﹤0.01% | 147 |
|
|
2021
Q3 | $760K | Buy |
6,066
+37
| +0.6% | +$4.79K | 0.01% | 125 |
|
|
2021
Q2 | $748K | Sell |
6,029
-35
| -0.6% | -$4.39K | 0.01% | 123 |
|
|
2021
Q1 | $716K | Buy |
6,064
+35
| +0.6% | +$4.1K | 0.01% | 125 |
|
|
2020
Q4 | $706K | Hold |
6,029
| – | – | 0.01% | 122 |
|
|
2020
Q3 | $627K | Sell |
6,029
-636
| -10% | -$63.9K | 0.01% | 120 |
|
|
2020
Q2 | $611K | Hold |
6,665
| – | – | 0.01% | 117 |
|
|
2020
Q1 | $601K | Hold |
6,665
| – | – | 0.01% | 119 |
|
|
2019
Q4 | $756K | Hold |
6,665
| – | – | 0.01% | 117 |
|
|
2019
Q3 | $724K | Sell |
6,665
-26,500
| -80% | -$2.76M | 0.01% | 114 |
|
|
2019
Q2 | $3.23M | Sell |
33,165
-86,388
| -72% | -$7.89M | 0.06% | 100 |
|
|
2019
Q1 | $10.9M | Sell |
119,553
-54,095
| -31% | -$4.84M | 0.21% | 91 |
|
|
2018
Q4 | $15.8M | Sell |
173,648
-62,822
| -27% | -$5.87M | 0.33% | 86 |
|
|
2018
Q3 | $23.3M | Hold |
236,470
| – | – | 0.39% | 83 |
|
|
2018
Q2 | $20.2M | Sell |
236,470
-69
| -0% | -$5.76K | 0.36% | 82 |
|
|
2018
Q1 | $19M | Sell |
236,539
-7,067
| -3% | -$583K | 0.35% | 84 |
|
|
2017
Q4 | $19.7M | Sell |
243,606
-536
| -0.2% | -$42.9K | 0.38% | 82 |
|
|
2017
Q3 | $19M | Sell |
244,142
-117
| -0% | -$9.71K | 0.37% | 83 |
|
|
2017
Q2 | $21.7M | Sell |
244,259
-820
| -0.3% | -$69.1K | 0.41% | 77 |
|
|
2017
Q1 | $19.7M | Buy |
245,079
+1,248
| +0.5% | +$97.5K | 0.4% | 77 |
|
|
2016
Q4 | $17.4M | Sell |
243,831
-566
| -0.2% | -$44.5K | 0.36% | 81 |
|
|
2016
Q3 | $21.1M | Sell |
244,397
-520
| -0.2% | -$45.3K | 0.42% | 75 |
|
|
2016
Q2 | $21.3M | Sell |
244,917
-1,664
| -0.7% | -$135K | 0.44% | 74 |
|
|
2016
Q1 | $18.5M | Sell |
246,581
-3,754
| -1% | -$283K | 0.39% | 73 |
|
|
2015
Q4 | $19.3M | Sell |
250,335
-717,324
| -74% | -$54M | 0.4% | 75 |
|
|
2015
Q3 | $64.8M | Sell |
967,659
-10,143
| -1% | -$747K | 1.33% | 30 |
|
|
2015
Q2 | $72.5M | Sell |
977,802
-110,148
| -10% | -$8.42M | 1.37% | 30 |
|
|
2015
Q1 | $84.8M | Buy |
1,087,950
+111,370
| +11% | +$8.44M | 1.53% | 24 |
|
|
2014
Q4 | $70.5M | Sell |
976,580
-26,343
| -3% | -$1.83M | 1.31% | 33 |
|
|
2014
Q3 | $62.1M | Buy |
1,002,923
+163,964
| +20% | +$10.4M | 1.21% | 35 |
|
|
2014
Q2 | $53.5M | Buy |
838,959
+170,482
| +26% | +$10.4M | 0.93% | 42 |
|
|
2014
Q1 | $41.1M | Sell |
668,477
-43,963
| -6% | -$2.56M | 0.74% | 51 |
|
|
2013
Q4 | $40.9M | Sell |
712,440
-137,530
| -16% | -$7.8M | 0.74% | 52 |
|
|
2013
Q3 | $45.3M | Buy |
849,970
+64,250
| +8% | +$3.46M | 0.98% | 41 |
|
|
2013
Q2 | $40.4M | Buy |
+785,720
| New | +$38.8M | 1.01% | 40 |
|
Other funds holding MDT
Riverbridge Partners's MDT Position: Q2 2025 in Review
Riverbridge Partners sold out of Medtronic (MDT) in Q2 2025, closing a stake of 3,415 shares — an estimated $307K sold.
Riverbridge Partners first reported a position in MDT in Q2 2013 and held it in 46 quarters. The position peaked at $84.8M in Q1 2015. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2025.
- Riverbridge Partners reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
- Riverbridge Partners sold 3,415 Medtronic shares in Q2 2025, an estimated $307K.
- Riverbridge Partners first reported a position in Medtronic in Q2 2013 and held it in 46 quarters.
- Riverbridge Partners's Medtronic position peaked at $84.8M in Q1 2015.
- 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.
Based on Riverbridge Partners's 13F filing for Q2 2025, filed 15 Jul 2025.